Jason Ancell | Director, Benefit Risk Science & Process
Gilead Sciences

Day 1: 14th October @ 11:45

Risk Management Tracking

This presentation highlights the evolving need to capture and track regulatory commitments in Risk Management Plans (RMPs) and Risk Evaluation and Mitigation Strategies (REMS). Drawing on recent experience implementing an RMP/REMS tracking tool, we will discuss the drivers for implementation, tool scope, operational considerations, and key lessons learned from both the sponsor and vendor perspectives.

This session will provide Patient Safety Risk Management experts with practical insights into how a structured tracking tool can improve visibility, strengthen oversight, and support consistent management of global risk management commitments.

Jason Ancell, Director, Benefit Risk Science & Process, Gilead Sciences

×

Jason Ancell / Risk Management Tracking

Jason Ancell, Director, Benefit Risk Science & Process,
Gilead Sciences

Jason Ancell, MBA, PMP, serves as Director, Benefit-Risk Science & Process at Gilead Sciences, where he leads and supports global risk management initiatives designed to enhance patient safety and ensure regulatory compliance. With more than 18 years of experience in U.S. REMS and global risk...

CloseMore

Christopher Long, Executive Director, Orbit by Feith Systems